INS and vitiligo: In addition, other mechanisms may contribute to the development of MetS in patients with vitiligo, such as insulin resistance, lipid profile disturbances and other metabolic disorders, due to the increased inflammatory cytokines and autoimmune reactions of the melanocytes.